SCHEMBL4247215

SCHEMBL4247215

CC(=O)c1ccc(CCC[N+](=O)[O-])cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 1/20 0.57
MAPK1 P28482 2/20 0.50
KMT2A Q03164 2/20 0.50
MAOB P27338 2/20 0.47
LMNA P02545 2/20 0.44
MMP12 P39900 1/20 0.41
MMP13 P45452 1/20 0.41
THRA P10827 2/20 0.41
THRB P10828 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
MEN1 O00255 1/20 0.41
NPC1 O15118 1/20 0.41
MAPT P10636 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CYP4A11 Q02928 2/20 0.40
RARB P10826 1/20 0.40
PLK1 P53350 1/20 0.40
MAOA P21397 1/20 0.40
GAA P10253 1/20 0.40
CYP4F2 P78329 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29201805 0.89 KMT2A (0.53) HSD17B10MAPK1KMT2AMAOBLMNA
SCHEMBL6795273 0.84 RARB (0.53) HSD17B10KMT2AMEN1MAPTRARB
SCHEMBL1290446 0.83 TSHR (0.50) HSD17B10KMT2AMAOBLMNAMAPT
SCHEMBL17457887 0.81 HSD17B10 (0.74) HSD17B10KMT2ALMNAMMP12MMP13
SCHEMBL11424105 0.81 HSD17B10 (0.74) HSD17B10KMT2ALMNAMMP12MMP13
SCHEMBL10785469 0.79 RARB (0.54) KMT2AMEN1MAPTRARB
SCHEMBL904232 0.78 ALDH1A1 (0.43) HSD17B10KMT2AMEN1NPC1
SCHEMBL1687902 0.78 ALDH1A1 (0.46) KMT2ALMNAL3MBTL1MEN1MAPT
SCHEMBL27765863 0.78 ESR1 (0.50) HSD17B10KMT2ALMNAL3MBTL1
SCHEMBL2731049 0.77 THRA (0.59) THRATHRBRARB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015107548-A1 IMPROVED FINGOLIMOD PROCESS EMCURE PHARMACEUTICALS LIMITED (IN) 2015-07-23 WO disclosed
WO-2012056458-A2 INTERMEDIATE COMPOUNDS AND PROCESS FOR THE PREPARATION OF FINGOLIMOD MAPI PHARMA LTD. (IL) 2012-05-03 WO disclosed